PP 3.15 – 00207 A polyvalent HIV-1 virus-like particle formulation drives the majority of the infectious HIV-1 reservoir out of latency within CD4+ T cells of individuals receiving cART during chronic infection

• E. Arts,
• J. Pankrac,
• R. Ho,
• M.H. Ngo,
• J. Prodger,
• A. Redd,
• T. Quinn,
• C. Kovacs,
• J. Kasule,
• J. Mann

Affiliations

E. Arts

Western University, London, Canada

J. Pankrac

Western University, London, Canada

R. Ho

Western University, London, Canada

M.H. Ngo

Western University, London, Canada

J. Prodger

Western University, London, Canada

A. Redd

National Institutes of Health, Baltimore, USA

T. Quinn

National Institutes of Health, Baltimore, USA

C. Kovacs

University of Toronto, Toronto, Canada

J. Kasule

Rakai Health Sciences Program, Kalisizo, Uganda

J. Mann

University of Bristol, Bristol, United Kingdom